title: Monotypic epithelioid angiomyolipoma of the liver with TFE3 expression.
authors.forename: Mei-Chin
authors.initials: MC
authors.lastname: Wen
authors.forename: Yee-Jee
authors.initials: YJ
authors.lastname: Jan
authors.forename: Mu-Chun
authors.initials: MC
authors.lastname: Li
authors.forename: John
authors.initials: J
authors.lastname: Wang
authors.forename: Anderson
authors.initials: A
authors.lastname: Lin
mesh_terms: D000328:Adult; D018207:Angiomyolipoma / Q000378:metabolism* / Q000473:pathology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / Q000096:biosynthesis*; D014408:Biomarkers, Tumor / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000378:metabolism* / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D016609:Neoplasms, Second Primary / Q000378:metabolism / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D014408:Biomarkers, Tumor; C069203:TFE3 protein, human; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone